Clinical Performance of Two Daily Disposable Soft Contact Lenses
Launched by ALCON RESEARCH · Nov 15, 2021
Trial Information
Current as of August 28, 2025
Completed
Keywords
ClinConnect Summary
Subjects will be expected to attend 3 visits. Subjects will be expected to wear their study contact lenses every day for at least 10 hours per day over an 8-day period for each study lens type. The total duration of a subject's participation in the study will be up to 22 days.
Gender
ALL
Eligibility criteria
- Key Inclusion Criteria:
- • Successful wear of spherical soft contact lenses with at least 3 months wearing experience, with a minimum wearing time of 5 days per week and 10 hours per day.
- • Willing to wear habitual spectacles for vision correction when study lenses are not worn, as needed.
- • Willing to wear contact lenses for at least 16 hours on the day prior to Visit 2 and the day prior to Visit 3.
- • Other protocol-defined inclusion criteria may apply.
- Key Exclusion Criteria:
- • Participation in a clinical trial within the previous 30 days or currently enrolled in any clinical trial.
- • Habitual PRECISION1, Biotrue, and DAILIES TOTAL1 contact lens wear.
- • Monovision and multifocal lens wear.
- • Other protocol-defined exclusion criteria may apply.
About Alcon Research
Alcon Research is a leading global company dedicated to advancing eye care through innovative research and development. As a subsidiary of Novartis, Alcon focuses on the development of cutting-edge products and therapies for vision correction and eye health, including surgical, pharmaceutical, and consumer eye care solutions. With a commitment to enhancing the quality of life for patients worldwide, Alcon Research conducts rigorous clinical trials to evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of care. Through collaboration with healthcare professionals and institutions, Alcon remains at the forefront of ophthalmic advancements, driving progress in the field of vision science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Medina, Minnesota, United States
Shawnee Mission, Kansas, United States
Tallahassee, Florida, United States
Maitland, Florida, United States
Medina, Minnesota, United States
Granville, Ohio, United States
Wichita Falls, Texas, United States
Tallahassee, Florida, United States
Franklin Park, Illinois, United States
Shawnee Mission, Kansas, United States
Wichita Falls, Texas, United States
Weston, Wisconsin, United States
Maitland, Florida, United States
Granville, Ohio, United States
Franklin Park, Illinois, United States
Weston, Wisconsin, United States
Patients applied
Trial Officials
Clinical Trial Lead, Vision Care
Study Director
Alcon Research, LLC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials